生物活性 | |||
---|---|---|---|
描述 | LY3000328 is a non-covalent, non-peptidic and selective Cathepsin S inhibitor with IC50 values of 7.7nM and 1.67nM for hCathepsin S and mCathepsin S, respectively. Oral administration of LY3000328, BID, for 28 days reduced aortic diameter induced by CaCl2 by 58%, 83% and 87% at dose of 1, 3 and 10mg/kg[1]. LY3000328 showed cleared quickly from plasma. A Phase 1 study of LY-3000328 has been completed.[2]. | ||
作用机制 | LY3000328 binds to the S2 and S3 subsites of Cathepsin S without interacting with the active site Cys25.[1] |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.06mL 0.41mL 0.21mL |
10.32mL 2.06mL 1.03mL |
20.64mL 4.13mL 2.06mL |
参考文献 |
---|